| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Z Y Tang | |
| P2860 | cites work | Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma | Q24563486 |
| Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group | Q28241816 | ||
| Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study | Q28249485 | ||
| Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP | Q28272211 | ||
| The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice | Q29620765 | ||
| Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics | Q33329325 | ||
| Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients | Q33503017 | ||
| Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial | Q33871980 | ||
| Cancer statistics, 1998. | Q34065873 | ||
| Should hepatomas be treated with hepatic resection or transplantation? | Q34281054 | ||
| Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis. | Q34445340 | ||
| Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection | Q34503100 | ||
| Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation | Q34505935 | ||
| Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma | Q34507461 | ||
| Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma | Q34743529 | ||
| Early hepatocellular carcinoma as an entity with a high rate of surgical cure | Q34754443 | ||
| Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study | Q35349653 | ||
| Differential expression of laminin receptors in human hepatocellular carcinoma | Q35353520 | ||
| Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. | Q55067548 | ||
| High frequency of expression of MAGE genes in human hepatocellular carcinoma. | Q57205523 | ||
| Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma | Q57981011 | ||
| Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma | Q58022064 | ||
| Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients | Q58022236 | ||
| Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience | Q58236150 | ||
| mRNA levels of nm23 in murine ascites hepatoma (H22) clones with different lymphatic metastatic potential | Q70843007 | ||
| Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: evaluation with analysis of 72 patients | Q70879309 | ||
| Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues | Q71007109 | ||
| Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group | Q71073938 | ||
| A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Brescia HCC Study | Q73105382 | ||
| Inhibitory effects of synthetic beta peptide on invasion and metastasis of liver cancer | Q73106338 | ||
| Percutaneous microwave coagulation therapy for hepatocellular carcinoma located on the surface of the liver | Q73131378 | ||
| Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection | Q73147171 | ||
| Integrin alpha6beta1 plays a significant role in the attachment of hepatoma cells to laminin | Q73156235 | ||
| Percutaneous ethanol injection therapy in 47 cirrhotic patients with hepatocellular carcinoma 5 cm or less: a long-term result | Q73186076 | ||
| Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor | Q73193733 | ||
| Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma | Q73196773 | ||
| Expression of MAGE genes and survival in patients with hepatocellular carcinoma | Q73198725 | ||
| Expression of urokinase-type plasminogen activator receptor in hepatocellular carcinoma | Q73208977 | ||
| Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma | Q73208981 | ||
| Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma | Q73212119 | ||
| The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma | Q73229768 | ||
| MAGE-1 and related MAGE gene expression may be associated with hepatocellular carcinoma | Q73258218 | ||
| N-acetylglucosaminyltransferase V activity in metastatic models of human hepatocellular carcinoma in nude mice | Q73292148 | ||
| Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study | Q73340869 | ||
| Implications of human macrophage metalloelastase and vascular endothelial growth factor gene expression in angiogenesis of hepatocellular carcinoma | Q73355887 | ||
| Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study | Q73363091 | ||
| Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. | Q45754630 | ||
| Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1. | Q45756188 | ||
| Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study | Q45757696 | ||
| Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis. | Q45760937 | ||
| p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. | Q45760939 | ||
| Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation | Q45859195 | ||
| In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene | Q45880474 | ||
| Gene therapy for hepatocellular carcinoma: progress but many stones yet unturned! | Q45880564 | ||
| Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy | Q45885495 | ||
| Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter. | Q45890138 | ||
| Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice | Q45890334 | ||
| Phase II trial of oral beta-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157). | Q46031237 | ||
| Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans | Q46506267 | ||
| Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness. | Q47262968 | ||
| Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials | Q47612936 | ||
| Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis? | Q47734769 | ||
| Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma | Q47866457 | ||
| Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma | Q47912418 | ||
| Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver | Q47993681 | ||
| Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma | Q48029915 | ||
| Complications associated with transcatheter arterial embolization for hepatic tumors | Q50157187 | ||
| Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. | Q50650208 | ||
| Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma. | Q50886330 | ||
| Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. | Q51512383 | ||
| Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. | Q52909973 | ||
| Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. | Q53350866 | ||
| Interferon-alpha modulates resistance to cisplatin in three human hepatoma cell lines. | Q54083597 | ||
| Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma. | Q54217111 | ||
| p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation | Q36291789 | ||
| Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study | Q36431812 | ||
| Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma | Q36619878 | ||
| New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis | Q38273658 | ||
| Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma | Q38323147 | ||
| The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma | Q38336028 | ||
| Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression | Q38467523 | ||
| Hepatitis B vaccination and hepatocellular carcinoma in Taiwan | Q38505340 | ||
| Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein | Q38527672 | ||
| Estimates of the worldwide mortality from 25 cancers in 1990. | Q39358305 | ||
| Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas | Q39486033 | ||
| Study of angiogenesis induced by metastatic and non-metastatic liver cancer by corneal micropocket model in nude mice | Q39592414 | ||
| Focal therapeutic efficacy of transcatheter arterial infusion of styrene maleic acid neocarzinostatin for hepatocellular carcinoma | Q40627620 | ||
| Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells | Q40925555 | ||
| Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma | Q40952453 | ||
| Primary prevention of hepatocellular carcinoma | Q40957770 | ||
| The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells | Q40962848 | ||
| Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20. | Q41005703 | ||
| p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus. | Q41022692 | ||
| In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2. | Q41068483 | ||
| Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer | Q41131284 | ||
| Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials | Q41419107 | ||
| Chronic infection with hepatitis G virus in relation to hepatocellular carcinoma among non-Asians in Los Angeles County, California | Q41691096 | ||
| Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma | Q41738570 | ||
| 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals | Q42536319 | ||
| Highly metastatic hepatocellular carcinomas induced in male F344 rats treated with N-nitrosomorpholine in combination with other hepatocarcinogens show a high incidence of p53 gene mutations along with altered mRNA expression of tumor-related genes | Q42551208 | ||
| Hepatoma-specific gene therapy through retrovirus-mediated and targeted gene transfer using an adenovirus carrying the ecotropic receptor gene | Q42808815 | ||
| Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study | Q42981575 | ||
| Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients | Q42981929 | ||
| Does hepatitis GB virus-C infection cause hepatocellular carcinoma in black Africans? | Q42984727 | ||
| GB virus-C RNA in Japanese patients with hepatocellular carcinoma and cirrhosis | Q42984892 | ||
| A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Brescia HCC Study | Q42985833 | ||
| Hepatitis G infection: role in cryptogenic chronic liver disease and primary liver cell cancer in the UK. Trent Hepatitis C virus Study Group. | Q42988996 | ||
| In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions | Q42989419 | ||
| Hepatitis C virus 1b(II) infection and development of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma: a case-control study in Japan | Q42990884 | ||
| GB virus C/hepatitis G virus infection among patients with hepatocellular carcinoma in the inshore area of the Yangtze River, China | Q42991790 | ||
| Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study | Q42993513 | ||
| The effect of retreatment with interferon-alpha on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C. | Q42996800 | ||
| Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice | Q43601327 | ||
| Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. | Q43790506 | ||
| A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma | Q44132600 | ||
| Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection | Q44358421 | ||
| Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma | Q44678038 | ||
| Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis | Q44916075 | ||
| Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer | Q45225251 | ||
| High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma | Q45746725 | ||
| Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo | Q45747421 | ||
| Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene | Q45747425 | ||
| A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma. The Brescia HCC Study | Q45748737 | ||
| Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil | Q45749012 | ||
| A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China | Q45753633 | ||
| Role of beta1 integrins in adhesion and invasion of hepatocellular carcinoma cells | Q77716515 | ||
| Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response | Q77795200 | ||
| KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases | Q77813158 | ||
| The abundance of NM23-H1 mRNA is related with in situ microenvironment and intrahepatic metastasis in hepato-cellular carcinoma | Q77813176 | ||
| Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis | Q77857254 | ||
| Establishment of a lymph node metastatic model of mouse hepatocellular carcinoma Hca-F cells in C3H/Hej mice | Q77879164 | ||
| Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up | Q77887481 | ||
| Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence | Q77933504 | ||
| Vascularization of small hepatocellular carcinomas: correlation with differentiation | Q77937042 | ||
| Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma | Q77950725 | ||
| Microvessel density of hepatocellular carcinoma: its relationship with prognosis | Q77965086 | ||
| Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis | Q78044194 | ||
| Clinical implications of telomerase activity in resected hepatocellular carcinoma | Q78056377 | ||
| Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma | Q78074716 | ||
| Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma | Q78076240 | ||
| Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma | Q78140633 | ||
| Alterations of CDKN2(p16/MTS1) exon 2 in human hepatocellular carcinoma | Q84144955 | ||
| P53 mutations may be related to tumor invasiveness of human hepatocellular-carcinoma in china | Q84152637 | ||
| Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats | Q73365650 | ||
| Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus | Q73370593 | ||
| Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan | Q73381818 | ||
| Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center | Q73441848 | ||
| Clinical results of radiofrequency hyperthermia for malignant liver tumors | Q73516915 | ||
| The role of telomerase activity in hepatocellular carcinoma | Q73531580 | ||
| Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma | Q73623064 | ||
| Expression of the integrin alpha5 subunit and its mediated cell adhesion in hepatocellular carcinoma | Q73686811 | ||
| Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20 | Q73736400 | ||
| Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma | Q73746406 | ||
| Increase in primary liver cancer in the UK, 1979-94 | Q73818313 | ||
| Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance | Q73857025 | ||
| Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma | Q73908738 | ||
| High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential | Q73929826 | ||
| Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver | Q74172274 | ||
| Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial | Q74195334 | ||
| Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial | Q74250283 | ||
| Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres | Q74256633 | ||
| Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis | Q74397618 | ||
| Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients | Q74404919 | ||
| Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry | Q74456158 | ||
| Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1 | Q74484550 | ||
| Significance of nm23 mRNA expression in human hepatocellular carcinoma | Q74501007 | ||
| Rising incidence of hepatocellular carcinoma in the United States | Q74595692 | ||
| Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection | Q74629352 | ||
| Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice | Q74686412 | ||
| Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation | Q74776352 | ||
| Preoperative chemoembolization of hepatocellular carcinoma: a comparative study | Q74830352 | ||
| Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study | Q77051802 | ||
| Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective | Q77058262 | ||
| Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC | Q77059950 | ||
| Expression of the MAGE gene family in human hepatocellular carcinoma | Q77214108 | ||
| Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma | Q77214396 | ||
| Hepatic resection for hepatocellular carcinoma -- Japanese experience | Q77214423 | ||
| Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma | Q77215000 | ||
| Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma | Q77321925 | ||
| Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas | Q77340406 | ||
| Progress and prospects in hepatocellular carcinoma surgery | Q77346466 | ||
| Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance | Q77355564 | ||
| Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy | Q77386995 | ||
| KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma | Q77598559 | ||
| Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma | Q77637965 | ||
| Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma | Q77655635 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 445-454 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Hepatocellular carcinoma--cause, treatment and metastasis | |
| P478 | volume | 7 |
| Q43290360 | A case of recurrent metastatic hepatocellular cancer controlled with immunotherapy and antiviral therapy following resection |
| Q39707910 | A clinicopathological model to predict bone metastasis in hepatocellular carcinoma |
| Q92992168 | A meta-analysis of MDR1 polymorphisms rs1128503 and rs1045642 and susceptibility to hepatocellular carcinoma |
| Q36617021 | A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China |
| Q35172998 | A survey on herbal management of hepatocellular carcinoma |
| Q34721998 | A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. |
| Q41959082 | Adenovirus mediated CTLA4Ig gene inhibits infiltration of immune cells and cell apoptosis in rats after liver transplantation |
| Q36065671 | Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies |
| Q36180341 | Alteration of p53 and p21 during hepatocarcinogenesis in tree shrews |
| Q30724233 | Anti-hepatoma activity of resveratrol in vitro |
| Q40649101 | Anti-metastatic effects of aqueous extract of Helixanthera parasitica. |
| Q48115152 | Antioxidant Activity of Zein Hydrolysates from Zea Species and Their Cytotoxic Effects in a Hepatic Cell Culture. |
| Q36178141 | Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70. |
| Q36474380 | Antitumor immunopreventive effect in mice induced by DNA vaccine encoding a fusion protein of alpha-fetoprotein and CTLA4. |
| Q43066620 | Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma |
| Q28211769 | Applying a highly specific and reproducible cDNA RDA method to clone garlic up-regulated genes in human gastric cancer cells |
| Q35010414 | Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China? |
| Q39001861 | Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro |
| Q33684950 | Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis |
| Q40612642 | Association of Vimentin overexpression and hepatocellular carcinoma metastasis |
| Q42695141 | Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1. |
| Q24803307 | Atypical presentation of hepatocellular carcinoma: a mass on the left thoracic wall |
| Q36308291 | Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma. |
| Q36497142 | Baseline characterization of patients aged 70 years and above with hepatocellular carcinoma |
| Q40359283 | Brain metastases from hepatocellular carcinoma in US patients |
| Q35783484 | Brain metastasis of hepatocellular carcinoma: A case report and review of the literature |
| Q41636948 | Caspase-2 deficiency accelerates chemically induced liver cancer in mice |
| Q37275063 | Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor |
| Q37037266 | Cationic liposome-mediated transfection of CD40 ligand gene inhibits hepatic tumor growth of hepatocellular carcinoma in mice |
| Q37127602 | Cationic polybutyl cyanoacrylate nanoparticles for DNA delivery |
| Q35010501 | Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma |
| Q30558695 | Challenges of incorporating gene expression data to predict HCC prognosis in the age of systems biology |
| Q34521144 | Changing patterns of traumatic bile duct injuries: a review of forty years experience |
| Q41601067 | Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma |
| Q33868324 | Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients |
| Q28483895 | Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B |
| Q35010409 | Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma |
| Q37435974 | Combined analysis of serum alpha-fetoprotein and MAGE-A3-specific cytotoxic T lymphocytes in peripheral blood for diagnosis of hepatocellular carcinoma |
| Q42268453 | Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma. |
| Q31156779 | Combined interventional therapies of hepatocellular carcinoma |
| Q43159585 | Combined small bowel and reduced auxiliary liver transplantation: case report |
| Q55303619 | Comparative proteomics of side population cells derived from human hepatocellular carcinoma cell lines with varying metastatic potentials. |
| Q35574968 | Comparison of tissue pressure and ablation time between the LeVeen and cool-tip needle methods |
| Q41983590 | Construction and expression of recombined human AFP eukaryotic expression vector |
| Q30724292 | Construction of HCV-core gene vector and its expression in cholangiocarcinoma |
| Q42695574 | Construction of IL-2 gene-modified human hepatocyte and its cultivation with microcarrier |
| Q30724968 | Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma |
| Q40600361 | Construction of a targeting adenoviral vector carrying AFP promoter for expressing EGFP gene in AFP-producing hepatocarcinoma cell |
| Q34382597 | Construction of recombinant eukaryotic expression plasmid containing murine CD40 ligand gene and its expression in H22 cells |
| Q44918009 | Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging |
| Q35491733 | Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer. |
| Q40447828 | Cost-effective method of siRNA preparation and its application to inhibit hepatitis B virus replication in HepG2 cells. |
| Q43093342 | Current management strategy of hepatocellular carcinoma |
| Q39525770 | Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9. |
| Q34606266 | DNA methyltransferase 3B promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese Han nationality population: a case-control study |
| Q40697710 | DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line |
| Q51162288 | Decreased expression of the human carbonyl reductase 2 gene HCR2 in hepatocellular carcinoma. |
| Q34382573 | Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma |
| Q43201114 | Detection of HBV, PCNA and GST-pi in hepatocellular carcinoma and chronic liver diseases |
| Q34382626 | Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT. |
| Q33830713 | Direct in vivo injection of 131I-GMS and its distribution and excretion in rabbit |
| Q36014160 | Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro. |
| Q34974277 | Dynamical observation on biological progression of VX2 liver tumors to identify the optimal time for intervention in animal models |
| Q42093589 | EF24 Suppresses Invasion and Migration of Hepatocellular Carcinoma Cells In Vitro via Inhibiting the Phosphorylation of Src. |
| Q37564406 | EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway |
| Q30921046 | Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity |
| Q41910185 | Effects of blueberries on migration, invasion, proliferation, the cell cycle and apoptosis in hepatocellular carcinoma cells |
| Q35825117 | Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients |
| Q38771692 | Effects of nitric oxide on the biological behavior of HepG2 human hepatocellular carcinoma cells |
| Q36474373 | Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization |
| Q87367003 | Effects of parenteral nutrition with and without GH on the GH/IGF-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis |
| Q36213803 | Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis |
| Q41817486 | Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma |
| Q36109796 | Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma |
| Q37031730 | Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma |
| Q40600338 | Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway |
| Q50672893 | Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective. |
| Q38101901 | Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins |
| Q30831603 | Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98. |
| Q34090895 | Establishment of animal models with orthotopic hepatocellular carcinoma |
| Q36415612 | Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. |
| Q42798888 | Establishment of cell lines from a primary hepatocellular carcinoma and its metastatis |
| Q40557819 | Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis |
| Q35059751 | Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma. |
| Q36309190 | Experimental study of anti-tumor effects of polysaccharides from Angelica sinensis |
| Q41920398 | Experimental study on the feasibility and safety of radiofrequency ablation for secondary splenomagely and hypersplenism |
| Q36309170 | Experimental study on therapeutic effect of in vivo expression of Cell I-Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma |
| Q36308092 | Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma |
| Q44943436 | Expression and prognostic value of Ars2 in hepatocellular carcinoma |
| Q36309178 | Expression and significance of RhoC gene in hepatocellular carcinoma |
| Q31039293 | Expression of liver cancer associated gene HCCA3. |
| Q36308973 | Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues |
| Q42120610 | Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis |
| Q43058499 | Expression of transforming growth factor-alpha and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance. |
| Q35804121 | Extrahepatic metastases as initial manifestations of hepatocellular carcinoma: an Egyptian experience |
| Q33692511 | Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness |
| Q36067465 | Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma |
| Q47965988 | Gene cloning of murine alpha-fetoprotein gene and construction of its eukaryotic expression vector and expression in CHO cells |
| Q40568445 | Gene expression in intrahepatic tumors through DNA recombination by a replication-activated adenovirus vector |
| Q36178624 | Gene expression profiles of hepatoma cell line HLE. |
| Q36474291 | Genomic instability of murine hepatocellular carcinomas with low and high metastatic capacities |
| Q36568490 | Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis. |
| Q36178658 | Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma. |
| Q41985642 | HBV cccDNA in patients' sera as an indicator for HBV reactivation and an early signal of liver damage |
| Q40356029 | HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma |
| Q34368658 | Hepatocellular carcinoma patients highly and specifically expressing XAGE-1 exhibit prolonged survival |
| Q33208819 | Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up |
| Q87725770 | Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression |
| Q36309132 | High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma |
| Q34382727 | Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population |
| Q34873314 | IPA-3 inhibits the growth of liver cancer cells by suppressing PAK1 and NF-κB activation |
| Q51897320 | Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
| Q36836530 | Influence of angiotensin I-converting enzyme gene polymorphism on hepatocellular carcinoma risk in China |
| Q36506308 | Influence of intrauterine injection of rat fetal hepatocytes on rejection of rat liver transplantation |
| Q40250428 | Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor |
| Q33868191 | Inhibitory effect of antisense vascular endothelial growth factor RNA on the profile of hepatocellular carcinoma cell line in vitro and in vivo |
| Q36308179 | Integrin gene expression profiles of human hepatocellular carcinoma |
| Q28280015 | KIAA0008 gene is associated with invasive phenotype of human hepatocellular carcinoma--a functional analysis |
| Q54117518 | KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma. |
| Q83024598 | Laparoscopic repeat resection of recurrent hepatocellular carcinoma |
| Q28068437 | Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma |
| Q27023744 | Linking metabolism and epigenetic regulation in development of hepatocellular carcinoma |
| Q34976928 | Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China |
| Q35784062 | Local recurrence is an important prognostic factor of hepatocellular carcinoma |
| Q38854451 | Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma |
| Q36190740 | Maxizyme-mediated specific inhibition on mutant-type p53 in vitro |
| Q36316057 | Mechanical properties of hepatocellular carcinoma cells. |
| Q42875933 | Mechanical stiffness of liver tissues in relation to integrin β1 expression may influence the development of hepatic cirrhosis and hepatocellular carcinoma |
| Q85943613 | Mediastinal hepatocellular carcinoma with unknown primary: an unusual and rare presentation |
| Q82421694 | MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma |
| Q34605680 | Molecular profiling of hepatocellular carcinomas by cDNA microarray |
| Q39224084 | NRP-1 silencing suppresses hepatocellular carcinoma cell growth in vitro and in vivo |
| Q33474444 | Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells |
| Q36496286 | Nuclear and mitochondrial DNA microsatellite instability in hepatocellular carcinoma in Chinese. |
| Q37316681 | Orthotopic liver transplantation as a rescue operation for recurrent hepatocellular carcinoma after partial hepatectomy |
| Q41092069 | Outcomes of metastatic spinal cord compression secondary to primary hepatocellular carcinoma with multidisciplinary treatments |
| Q43211650 | Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system |
| Q43005656 | Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome |
| Q34144126 | Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance |
| Q36308536 | P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection |
| Q52643619 | PDK1-WNK1 signaling is affected by HBx and involved in the viability and metastasis of hepatic cells. |
| Q36308377 | Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma |
| Q37209921 | Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma. |
| Q45728735 | Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning |
| Q36316052 | Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. |
| Q36190630 | Preparation and characterization of polyclonal antibodies against ARL-1 protein |
| Q31114066 | Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization |
| Q36178581 | Prevalence of hepatitis B and C markers among refugees in Athens |
| Q36308644 | Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines |
| Q64274814 | Profiling of LINE-1-Related Genes in Hepatocellular Carcinoma |
| Q42270431 | Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy |
| Q36067470 | Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia |
| Q37738005 | Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues |
| Q30396930 | Radiofrequence ablation of liver cancers |
| Q37687603 | Recombinant heat shock protein 70 functional peptide and alpha-fetoprotein epitope peptide vaccine elicits specific anti-tumor immunity |
| Q39882641 | Reduction of anion exchanger 2 expression induces apoptosis of human hepatocellular carcinoma cells |
| Q36178655 | Right trisectionectomy for primary liver cancer |
| Q43159874 | Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE. |
| Q40552306 | Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma |
| Q92481953 | SORBS2, mediated by MEF2D, suppresses the metastasis of human hepatocellular carcinoma by inhibitiing the c-Abl-ERK signaling pathway |
| Q36474696 | Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B |
| Q35038304 | Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma |
| Q43137654 | Serum miR-224 reflects stage of hepatocellular carcinoma and predicts survival |
| Q40555471 | Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics |
| Q45143602 | Study of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines |
| Q36308830 | Study on hepatocelluar carcinoma-associated hepatic arteriovenous shunt using multidetector CT |
| Q40368724 | Suppression of Human Liver Cancer Cell Migration and Invasion via the GABAA Receptor |
| Q41891731 | Systematic analysis of molecular mechanisms for HCC metastasis via text mining approach |
| Q36178340 | Targeted ribonuclease can inhibit replication of hepatitis B virus |
| Q38483960 | The abnormalities of chromosome 8 in two hepatocellular carcinoma cell clones with the same genetic background and different metastatic potential |
| Q36178319 | The analysis of gamma-glutamyl transpeptidase gene in different type liver tissues |
| Q90404093 | The long noncoding RNA NORAD enhances the TGF-β pathway to promote hepatocellular carcinoma progression by targeting miR-202-5p |
| Q36209697 | The microcell mediated transfer of human chromosome 8 into highly metastatic rat liver cancer cell line C5F. |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
| Q34582844 | The prognostic significance of clinical and pathological features in hepatocellular carcinoma |
| Q82665040 | The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma |
| Q35177271 | The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma |
| Q37505533 | The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma |
| Q27016620 | The role of p21-activated kinases in hepatocellular carcinoma metastasis |
| Q38661239 | The role of thiazolidinediones in hepatocellular carcinoma risk reduction: a population-based cohort study in Taiwan |
| Q30400478 | Three-dimensional contrast-enhanced MR angiography in diagnosis of portal vein involvement by hepatic tumors |
| Q34605140 | Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma |
| Q36308654 | Total vascular exclusion technique for resection of hepatocellular carcinoma |
| Q58591823 | Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition |
| Q30396923 | Ultrasonic aspiration hepatectomy for 136 patients with hepatocellular carcinoma |
| Q90148815 | Upregulated Seizure-Related 6 Homolog-Like 2 Is a Prognostic Predictor of Hepatocellular Carcinoma |
| Q36085576 | Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice |
| Q35165954 | VP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication |
| Q36502592 | Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats. |
| Q34186700 | WSS25 Inhibits Growth of Xenografted Hepatocellular Cancer Cells in Nude Mice by Disrupting Angiogenesis via Blocking Bone Morphogenetic Protein (BMP)/Smad/Id1 Signaling |
| Q87449092 | miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma |
| Q41507763 | miR-92a promotes hepatocellular carcinoma cells proliferation and invasion by FOXA2 targeting |
| Q40707172 | p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis |
| Q34717513 | p53 codon 72 polymorphism and liver cancer susceptibility: a meta-analysis of epidemiologic studies |
| Q40688905 | p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha |
| Q40513757 | siRNA-mediated inhibition of HBV replication and expression |
Search more.